Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis

Blood

Volumn 85, Issue 3, 1995, Pages 757-764

  Shima, Yoshihito ^a   Nishimoto, Norihiro ^a   Ogata, Atsushi ^a   Fujii, Yoshitaka ^a   Yoshizaki, Kazuyuki ^a   Kishimoto, Tadamitsu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; COLONY STIMULATING FACTOR RECEPTOR; CYTOKINE RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN GP 130; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON RECEPTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; MONOCLONAL ANTIBODY; STEM CELL FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MYELOMA CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0028942109     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v85.3.757.bloodjournal853757     Document Type: Article

References (38)

1. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83, 1988
2. Klein B, Zhang X-G, Jourdan M, Content J, Houssiau F, Anden L, Piechaczyk M, Bataille R: Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73:517, 1989
3. Anderson KC, Jones RM, Morimoto C, Leavitt P, Barut BA: Response patterns of purified myeloma cells to hematopoietic growth factors. Blood 73:1915, 1989
4. Zhang X-G, Gu J-J, Lu Z-Y, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, Klein B: Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp 130. J Exp Med 177:1337, 1994
5. Nishimoto N, Ogata A, Shima Y, Tani Y, Ogawa H, Nakagawa M, Sugiyama H, Yoshizaki K, Kishimoto T: Oncostatin M, leukemia inhibitory factor, and interleukin-6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. J Exp Med 177:1343, 1994
6. Kawano M, Tanaka H, Ishikawa H, Nobuyoshi M, Iwato K, Asaoku H, Tanabe O, Kuramoto A: Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood 73:2145, 1989
7. Carter A, Merchav S, Silvian-Draxler I, Tatarsky I: The role of interleukin-1 and tumor necrosis factor-α in human multiple myeloma. Br J Haematol 74:424, 1990
8. Zhang X-G, Bataille R, Jourdan M, Saeland S, Banchereau J, Mannoni P, Klein B: Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood 76:2599, 1990
9. Garrett IR, Durie BGM, Nedwin GE, Gillespie A, Bringman T, Sabatini M, Bertolini DR, Mundy GR: Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N Engl J Med 317:526, 1987
10. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD: IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-I release. J Immunol 144:4226, 1990
11. Bergui L, Schena M, Gaidano G, Riva M, Caligaris-Cappio F: Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J Exp Med 170:613, 1989
12. Portier M, Zhang X-G, Caron E, Lu Z-Y, Bataille R, Klein B: γ-interferon in multiple myeloma: Inhibition of interleukin-6 (IL-6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro. Blood 81:3076, 1993
13. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
14. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 267:10709, 1992
15. Schlossman S, et al: Leukocyte Typing V. New York, NY, Oxford 1994 (in press)
16. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
17. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin K-M, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301, 1989
18. Debatin K-M, Goldman CK, Waldmann TA, Krammer PH: APO-1 -induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81:2972, 1993
19. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
20. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
21. Iwato K, Kawano M, Asaoku H, Tanabe O, Tanaka H, Kuramoto A: Separation of human myeloma cells from bone marrow aspirates in multiple myeloma and their proliferation and M-protein secretion in vitro. Blood 72:562, 1988
22. Kawano M, Huang N, Harada H, Harada Y, Sakai A, Tanaka H, Iwato K, and Kuramoto A: Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood 82:564, 1993
23. Itoh N, Nagata S: A novel protein domain required for apoptosis. J Biol Chem 268:10932, 1993
24. Kerr JFR, Wyllie AH, Currie AR: Apotosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239, 1972
25. Flanagan JG, Leder P: The kit ligand: A cell surface molecule altered in steel mutant fibroblasts. Cell 63:185, 1990
26. Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VN, Birkett NC, Williams LR, Satyagol VN, Tung W, Bosselman RA, Mendiaz EA, Langley KE: Identification, purification, and biological characterization of hematopoietic stem cell factor from Buffalo rat liver-conditioned medium. Cell 63:195, 1990
27. Huang E, Nocka K, Beier DR, Chu T, Buck J, Lahm H, Wellner D, Leder P, Besner P: The hematopoietic growth factor KL is encoded by the SI locus and is the ligend of the c-kit receptor, the gene produce of the W locus. Cell 63:225, 1990
28. Möller P, Henne C, Leithäser F, Eichelmann A, Schmidt A, Brüderlein S, Dhein J, Krammer PH: Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas. Blood 81:2067, 1993
29. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigenmediated cell death. J Immunol 151:621, 1993
30. Finke J, Fritzen R, Ternes P, Trivedi P, Bross KJ, Lange W, Mertelsmann R, Dölken G: Expression of bcl-2 in Burkitt's lymphoma cell lines: Induction by latent Epstein-Barr virus genes. Blood 80:459, 1992
31. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G, and Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
32. Oltvai ZN, Milliman CL, and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609, 1993
33. - B cell compartment: Identification of two major tonsillar B cell subsets. Int Immunol 5:1259, 1993
34. Pandolfi F, Oliva A, Sacco G, Polidori V, Liberatore D, Mezzaroma I, Giovannetti A, Kurnick JT, Aiuti F: Fibroblast-derived factors preserve viability in vitro of mononuclear cells isolated from subjects with HIV-1 infection. AIDS 7:323, 1993
35. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, and Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759, 1994
36. Santos-Argumedo L, Teixeira C, Preece G, Kirkham PA, Parkhouse RME: A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels. J Immunol 151:3119, 1993
37. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
38. 2+-independent T cell-mediated cytotoxicity. J Exp Med 177:195, 1993